Elia Casirati
Milan, 20122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.
Journal: Nature medicine
Published: January 24, 2024
Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19].
Journal: Journal of hepatology
Published: January 05, 2024
Estrogen-ER-α axis induces PNPLA3 p.I148M protein variant to promote steatotic liver disease susceptibility in women.
Journal: Clinical and translational medicine
Published: December 06, 2023
Editorial: Unveiling new horizons for liver steatosis genetic variants beyond hepatocellular carcinoma diagnosis - exploring the potential of HSD17B13 inhibition.
Journal: Alimentary pharmacology & therapeutics
Published: September 13, 2023
Numerical refractive index correction for the stitching procedure in tomographic quantitative phase imaging.
Journal: Biomedical optics express
Published: June 14, 2022
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease.
Journal: Journal of hepatology
Published: March 11, 2022
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date.
Journal: Expert opinion on therapeutic targets
Published: December 14, 2021
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets.
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets.
Journal: JHEP reports : innovation in hepatology
Published: November 23, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026